UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The pharmacokinetics, pharmacodynamics and tolerability of dabigatran etexilate, a new oral direct thrombin inhibitor, in healthy male subjects

British journal of clinical pharmacology, 2007-09, Vol.64 (3), p.292-303

2007

Volltextzugriff (PDF)

The metabolism and disposition of the oral direct thrombin inhibitor, dabigatran, in humans

Drug metabolism and disposition, 2008-02, Vol.36 (2), p.386-399

2008

Volltextzugriff (PDF)

Predominant contribution of OATP1B3 to the hepatic uptake of telmisartan, an angiotensin II receptor antagonist, in humans

Drug metabolism and disposition, 2006-07, Vol.34 (7), p.1109-1115

2006

Volltextzugriff (PDF)

Concentration-dependent plasma protein binding of the novel dipeptidyl peptidase 4 inhibitor BI 1356 due to saturable binding to its target in plasma of mice, rats and humans

Journal of pharmacy and pharmacology, 2009-01, Vol.61 (1), p.55-62

2009

Volltextzugriff (PDF)

The impact of pharmacogenetics of metabolic enzymes and transporters on the pharmacokinetics of telmisartan in healthy volunteers

Pharmacogenetics and genomics, 2011-09, Vol.21 (9), p.523-530

2011

Volltextzugriff (PDF)

Establishment of a set of double transfectants coexpressing organic anion transporting polypeptide 1B3 and hepatic efflux transporters for the characterization of the hepatobiliary transport of telmisartan acylglucuronide

Drug metabolism and disposition, 2008-04, Vol.36 (4), p.796-805

2008

Volltextzugriff (PDF)

Pharmacokinetics of meloxicam in animals and the relevance to humans

Drug metabolism and disposition, 1998-06, Vol.26 (6), p.576

1998

Volltextzugriff (PDF)

Pharmacokinetics and Pharmacodynamics of Dabigatran Etexilate, an Oral Direct Thrombin Inhibitor, Are Not Affected by Moderate Hepatic Impairment

Journal of clinical pharmacology, 2008-12, Vol.48 (12), p.1411-1419

2008

Volltextzugriff (PDF)

Concentration-dependent plasma protein binding of the novel dipeptidyl peptidase 4 inhibitor BI 1356 due to saturable binding to its target in plasma of mice, rats and humans

Journal of pharmacy and pharmacology, 2009-01, Vol.61 (1), p.55-62

2009

Volltextzugriff (PDF)

Pharmacokinetics and Pharmacodynamics of Dabigatran Etexilate, an Oral Direct Thrombin Inhibitor, With Coadministration of Digoxin

Journal of clinical pharmacology, 2012-02, Vol.52 (2), p.243-250

2012

Volltextzugriff (PDF)

Coadministration of Dabigatran Etexilate and Atorvastatin: Assessment of Potential Impact on Pharmacokinetics and Pharmacodynamics

American journal of cardiovascular drugs : drugs, devices, and other interventions, 2009, Vol.9 (1), p.59-68

2009

Volltextzugriff (PDF)

The impact of pharmacogenetics of metabolic enzymes and transporters on the pharmacokinetics of telmisartan in healthy volunteers

Pharmacogenetics and genomics, 2011-06, p.1

2011

Volltextzugriff (PDF)

The pharmacokinetics, pharmacodynamics and tolerability of dabigatran etexilate, a new oral direct thrombin inhibitor, in healthy male subjects. Commentary

British journal of clinical pharmacology, 2007, Vol.64 (3)

2007

Volltextzugriff (PDF)

Automation of Blood Donor Testing for Infectious Diseases

Transfusion medicine and hemotherapy, 2007-01, Vol.34 (5), p.316-327

2007

Volltextzugriff (PDF)

Modelling the anti-migraine effects of BIBN 4096 BS : A new calcitonin gene-related peptide receptor antagonist

Clinical pharmacokinetics, 2006, Vol.45 (7), p.715-728

2006

Volltextzugriff (PDF)

Population pharmacokinetic modelling of BIBN 4096 BS, the first compound of the new class of calcitonin gene-related peptide receptor antagonists

European journal of pharmaceutical sciences, 2004-07, Vol.22 (4), p.287-295

2004

Volltextzugriff (PDF)

Altered drug disposition of the platelet activating factor antagonist apafant in mdr1a knockout mice

European journal of pharmaceutical sciences, 2002-08, Vol.16 (3), p.119-128

2002

Volltextzugriff (PDF)

Pharmacokinetics and Safety of Intravenous and Oral Telmisartan 20 mg and 120 mg in Subjects with Hepatic Impairment Compared with Healthy Volunteers

Journal of clinical pharmacology, 2000-12, Vol.40 (12), p.1355-1364

2000

Volltextzugriff (PDF)

Altered drug disposition of the platelet activating factor antagonist apafant in mdrla knockout mice

European journal of pharmaceutical sciences, 2002, Vol.16 (3), p.119-128

2002

Volltextzugriff (PDF)

Kaposi's sarcoma : a review of gene expression and ultrastructure of KS spindle cells in vivo

AIDS research and human retroviruses, 1992-10, Vol.8 (10), p.1753-1763

1992

Volltextzugriff (PDF)

Chemie an starren Grenzflächen, 10. Kinetisches Verhalten einiger an ,,Isothiocyanato-Aerosil"︁ immobilisierter Esterasen - Analogversuche mit Insulin

Liebigs Annalen der Chemie, 1988-10, Vol.1988 (10), p.965-971

1988

Volltextzugriff (PDF)

Rapid, sensitive and fully automated high-performance liquid chromatographic assay with fluorescence detection for sulmazole and metabolites

Journal of chromatography, 1983-01, Vol.278 (2), p.347-357

Roth, Willy

1983

Volltextzugriff (PDF)

Infection of human fibroblasts and osteoblast-like cells with HIV-1

AIDS (London), 1990-06, Vol.4 (6), p.527-535

1990

Volltextzugriff (PDF)

Pharmacokinetics and safety of intravenous and oral telmisartan 20 mg and 120 mg in subjects with hepatic impairment compared with healthy volunteers: Clinical Pharmacology of Telmisartan

Journal of clinical pharmacology, 2000, Vol.40 (12), p.1355-1364

2000

Volltextzugriff (PDF)

Sauerstoffbiologie für die ARA Basel

Wasser, Energie, Luft, 1984-01, Vol.76 (1-2), p.7

Roth, Willy

1984

Volltextzugriff (PDF)

1 – 25 von 59

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(47)
Mit Volltextzugriff
(44)

Publikationsform

Sprache

Englisch
(47)
Deutsch
(12)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The pharmacokinetics, pharmacodynamics and tolerability of dabigatran etexilate, a new oral direct thrombin inhibitor, in healthy male subjects

The metabolism and disposition of the oral direct thrombin inhibitor, dabigatran, in humans

Predominant contribution of OATP1B3 to the hepatic uptake of telmisartan, an angiotensin II receptor antagonist, in humans

Concentration-dependent plasma protein binding of the novel dipeptidyl peptidase 4 inhibitor BI 1356 due to saturable binding to its target in plasma of mice, rats and humans

The impact of pharmacogenetics of metabolic enzymes and transporters on the pharmacokinetics of telmisartan in healthy volunteers

Establishment of a set of double transfectants coexpressing organic anion transporting polypeptide 1B3 and hepatic efflux transporters for the characterization of the hepatobiliary transport of telmisartan acylglucuronide

Pharmacokinetics of meloxicam in animals and the relevance to humans

Pharmacokinetics and Pharmacodynamics of Dabigatran Etexilate, an Oral Direct Thrombin Inhibitor, Are Not Affected by Moderate Hepatic Impairment

Concentration-dependent plasma protein binding of the novel dipeptidyl peptidase 4 inhibitor BI 1356 due to saturable binding to its target in plasma of mice, rats and humans

Pharmacokinetics and Pharmacodynamics of Dabigatran Etexilate, an Oral Direct Thrombin Inhibitor, With Coadministration of Digoxin

Coadministration of Dabigatran Etexilate and Atorvastatin: Assessment of Potential Impact on Pharmacokinetics and Pharmacodynamics

The impact of pharmacogenetics of metabolic enzymes and transporters on the pharmacokinetics of telmisartan in healthy volunteers

The pharmacokinetics, pharmacodynamics and tolerability of dabigatran etexilate, a new oral direct thrombin inhibitor, in healthy male subjects. Commentary

Automation of Blood Donor Testing for Infectious Diseases

Modelling the anti-migraine effects of BIBN 4096 BS : A new calcitonin gene-related peptide receptor antagonist

Population pharmacokinetic modelling of BIBN 4096 BS, the first compound of the new class of calcitonin gene-related peptide receptor antagonists

Altered drug disposition of the platelet activating factor antagonist apafant in mdr1a knockout mice

Pharmacokinetics and Safety of Intravenous and Oral Telmisartan 20 mg and 120 mg in Subjects with Hepatic Impairment Compared with Healthy Volunteers

Altered drug disposition of the platelet activating factor antagonist apafant in mdrla knockout mice

Kaposi's sarcoma : a review of gene expression and ultrastructure of KS spindle cells in vivo

Chemie an starren Grenzflächen, 10. Kinetisches Verhalten einiger an ,,Isothiocyanato-Aerosil"︁ immobilisierter Esterasen - Analogversuche mit Insulin

Rapid, sensitive and fully automated high-performance liquid chromatographic assay with fluorescence detection for sulmazole and metabolites

Infection of human fibroblasts and osteoblast-like cells with HIV-1

Pharmacokinetics and safety of intravenous and oral telmisartan 20 mg and 120 mg in subjects with hepatic impairment compared with healthy volunteers: Clinical Pharmacology of Telmisartan

Sauerstoffbiologie für die ARA Basel

Suchergebnisse filtern